CoQ10 Supplement Ireland | Coenzyme Q10 Evidence Guide
Coenzyme Q10 is one of the most widely discussed supplements in Ireland, yet most content online is either generic or American-market focused. This guide is written specifically for Ireland — covering what CoQ10 is, what the evidence shows, how to choose the right dose and form, and where to buy it with nationwide Irish delivery.
CoQ10 (coenzyme Q10) is a fat-soluble compound produced by the body that plays a central role in cellular energy production and acts as an antioxidant. It is good for supporting mitochondrial energy metabolism, supplementing levels depleted by statin medications, and supporting reproductive function in both men and women. The most-studied supplemental dose is 100mg per day, taken with a fat-containing meal. Ubiquinone is the most clinically studied form. In Ireland, CoQ10 is a food supplement regulated by the FSAI — it is not a medicine and cannot be claimed to treat any disease.
Contents
- What is CoQ10 (coenzyme Q10)?
- What is CoQ10 good for? The evidence
- CoQ10 benefits for women
- CoQ10 benefits for men
- CoQ10 dosage: 100mg, 200mg, 600mg — what the evidence uses
- Ubiquinone vs ubiquinol: which form to choose
- CoQ10 and statins: what the evidence shows
- CoQ10 side effects and safety
- How long does CoQ10 take to work?
- Where to buy CoQ10 in Ireland
What is CoQ10 (coenzyme Q10)?
Coenzyme Q10 — also known as CoQ10, ubiquinone, or simply Q10 — is a fat-soluble, vitamin-like compound synthesised endogenously in virtually every cell of the human body. Its systematic chemical name is 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone, and it belongs to a family of compounds called quinones.
CoQ10 is concentrated in tissues with the highest energy demands. The heart, liver, and kidneys contain the greatest concentrations, reflecting the mitochondrial density of these organs. Approximately 95% of cellular CoQ10 is found in the inner mitochondrial membrane, where it is central to the electron transport chain.2
The body produces CoQ10 through a complex biosynthetic pathway that shares steps with cholesterol production — which is why statin medications, which block this pathway, also reduce endogenous CoQ10 synthesis. Dietary CoQ10 comes primarily from fatty fish, beef, pork, and whole grains, though food sources provide much smaller amounts than supplemental doses.
CoQ10 levels peak in the second decade of life and decline measurably thereafter. By age 80, plasma CoQ10 levels may be 40% lower than peak values.2 This age-related decline is the primary rationale for supplementation in older adults.
CoQ10 shuttles electrons between complexes I/II and complex III in the mitochondrial electron transport chain. This electrochemical gradient drives ATP synthase to produce adenosine triphosphate — the cell's primary energy currency.
In its reduced form (ubiquinol), CoQ10 donates electrons to neutralise reactive oxygen species in cell membranes and lipoproteins. It is one of the few fat-soluble antioxidants synthesised endogenously.
Ubiquinol regenerates oxidised vitamin E (alpha-tocopherol) back to its active antioxidant form. This interaction means CoQ10 status can influence the effectiveness of vitamin E in cell membranes.
CoQ10 is incorporated into cell membranes and mitochondrial membranes where it contributes to structural integrity and influences membrane fluidity, which affects receptor function and cellular signalling.
The heart muscle generates virtually all its energy aerobically via mitochondria. High CoQ10 concentrations in cardiac tissue reflect its dependence on efficient oxidative phosphorylation, particularly during increased workload.
CoQ10 is synthesised via the mevalonate pathway — the same metabolic route used in cholesterol production. HMG-CoA reductase inhibitors (statins) block this pathway, reducing both cholesterol and CoQ10 biosynthesis simultaneously.
What is CoQ10 good for? The evidence
CoQ10 has been studied across a wide range of clinical contexts. The quality of evidence varies considerably between applications — from well-powered RCTs to small pilot studies. This section summarises the key areas with an accurate representation of what the evidence does and does not support.
It is important to note that no health claims for CoQ10 are currently authorised under EC Regulation 1924/2006 as applied in Ireland. The following represents what published research has investigated, not licensed health claims.
A 2023 Cochrane-level systematic review by Flowers et al. examined CoQ10 supplementation in cardiac populations across multiple randomised controlled trials. The review found evidence of improvement in exercise tolerance and quality of life measures in some trial populations, with a generally favourable safety profile. The authors noted significant heterogeneity in dose, formulation, and patient population across included studies, which limits definitive conclusions.
Citation: Flowers N et al. Effects of coenzyme Q10 supplementation on cardiac outcomes: a systematic review and meta-analysis. Cochrane Database Syst Rev. 2023. — PubMed
A randomised, placebo-controlled trial by Skarlovnik et al. recruited 50 patients experiencing mild-to-moderate muscle symptoms on statin therapy. Participants received 50mg CoQ10 twice daily (100mg/day total) or placebo for 30 days. The CoQ10 group showed a statistically significant reduction in muscle pain and weakness scores compared to placebo. This is one of the more frequently cited RCTs supporting CoQ10 use in statin users.
Citation: Skarlovnik A et al. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms. Med Sci Monit. 2014;20:2183–2188. — PubMed
An updated meta-analysis by Xu et al. pooled data from multiple RCTs examining CoQ10 for statin-associated muscle symptoms (SAMS). The meta-analysis found modest but statistically significant improvements in pain scores, but highlighted substantial heterogeneity between trials in terms of dose, CoQ10 form, outcome measures, and patient population. The authors concluded that CoQ10 may be beneficial for SAMS but that evidence is insufficient to make a definitive recommendation. This is the appropriate level of confidence the evidence warrants.
Citation: Xu Z et al. Effect of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of RCTs. J Am Heart Assoc. 2021;10(13):e021169. — PubMed
A study by Ben-Meir et al. demonstrated that CoQ10 supplementation restored mitochondrial function in oocytes from aged mice, improving fertilisation rates and embryo quality. The proposed mechanism is that mitochondrial dysfunction in ageing oocytes reduces ATP available for spindle formation and chromosome segregation. While this is animal model data with limited direct human RCT evidence, it provides a mechanistic basis for CoQ10 use in reproductive contexts. Human trials in fertility are ongoing.
Citation: Ben-Meir A et al. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell. 2015;14(5):887–895. — PubMed
A meta-analysis by Lafuente et al. reviewed five RCTs examining CoQ10 supplementation in men with idiopathic infertility. Pooled analysis found statistically significant improvements in sperm concentration (p<0.001), motility (p<0.001), and morphology compared to placebo. Doses ranged from 200mg to 600mg per day over 3 to 6 months. The authors noted that while sperm parameter improvements were consistent, the effect on actual pregnancy rates requires further study in adequately powered trials.
Citation: Lafuente R et al. Coenzyme Q10 and male infertility: a meta-analysis. J Assist Reprod Genet. 2013;30(9):1147–1156. — PubMed
CoQ10 benefits for women
The keyword "CoQ10 benefits for women" is one of the highest-volume CoQ10 searches in Ireland, reflecting genuine consumer interest in this specific application. The evidence breaks down into two main areas: reproductive support and general antioxidant protection.
Reproductive and fertility support
Oocyte quality declines with age, and mitochondrial dysfunction is considered a key mechanism. CoQ10 is highly concentrated in oocytes — reflecting their extraordinary ATP demand during fertilisation and early embryo development. The Ben-Meir et al. (2015) study demonstrated that supplemental CoQ10 restored mitochondrial membrane potential in aged oocytes in a mouse model.6 Human data are more limited, but this mechanistic basis has made CoQ10 a widely discussed supplement among women over 35 pursuing natural conception or undergoing IVF.
Women taking CoQ10 for fertility purposes should be aware that this is an area where mechanistic and animal-model evidence is stronger than human RCT evidence. Discuss with your GP, fertility consultant, or reproductive specialist before use.
Perimenopause and energy
Perimenopause is associated with declining mitochondrial efficiency, which may contribute to fatigue and reduced exercise tolerance. Endogenous CoQ10 levels also decline with age through the same period. There is currently no large-scale, well-powered RCT specifically examining CoQ10 supplementation in perimenopausal women for these outcomes. Use in this context is based on mechanistic rationale rather than direct trial evidence in this population.
CoQ10 should not be taken during pregnancy or breastfeeding without medical advice. There is insufficient evidence to confirm safety in these populations. Always consult your GP or midwife before use.
CoQ10 benefits for men
The primary evidence base for CoQ10 in men relates to sperm function. Sperm are uniquely reliant on mitochondrial ATP for motility — the tail (flagellum) of a sperm cell contains a dense array of mitochondria arranged specifically to power its movement. CoQ10 concentration in sperm correlates with motility parameters in observational studies.
The meta-analysis by Lafuente et al. (2013), covering five RCTs and 228 participants, found consistent improvements in sperm concentration, motility, and morphology with CoQ10 supplementation versus placebo.7 Doses studied ranged from 200mg to 600mg per day over 3 to 6 months. At 100mg per day — the dose in the products stocked at Probiotic.ie — the relevant question is whether a lower dose achieves adequate plasma and tissue concentration for this purpose. Clinical trials in fertility have generally used higher doses.
Men on statin therapy represent a second group with a specific rationale for CoQ10. Statins reduce endogenous CoQ10 synthesis, and older men are the primary statin-using demographic in Ireland. This application is covered in detail in the section below.
CoQ10 dosage: 100mg, 200mg, 600mg — what the evidence uses
There is no EU Reference Intake established for CoQ10. Dose selection should be informed by the clinical context, based on what trial evidence has used for each application.
| Dose | Context in Evidence | Notes |
|---|---|---|
| 100mg/day | General supplementation, statin users (Skarlovnik et al. 2014), cardiac studies | Most common starting dose. Most widely available in Ireland. |
| 200mg/day | Male fertility RCTs (lower end), cardiac studies | Higher plasma CoQ10 levels achieved. Consider if 100mg provides insufficient response after 8+ weeks. |
| 300–600mg/day | Male fertility (Lafuente meta-analysis), some cardiac populations | Used in fertility trials. Clinical supervision advisable at this range. |
| Split dosing | Some RCTs use 2x daily dosing (e.g. 50mg twice daily) | Pharmacokinetic data suggest split dosing maintains more consistent plasma levels than single daily dose. |
CoQ10 is fat-soluble. Bioavailability is significantly higher when taken with a fat-containing meal. A 2020 review by Mantle and Dybring (Antioxidants, Basel) confirmed that oil-based softgel formulations achieve substantially better absorption than dry powder capsules.3 Both Doctor's Best and Healthy Origins CoQ10 softgels are suspended in olive oil — take with food for optimal absorption.
Ubiquinone vs ubiquinol: which form to choose
This is the most commonly misunderstood CoQ10 topic in Ireland. Marketing often positions ubiquinol as categorically superior, but the evidence is more nuanced.
- Most extensively studied in clinical trials
- Converted to ubiquinol in the body enzymatically
- Highly bioavailable in oil-based softgel formulations
- Wider range of published RCT evidence
- Generally lower cost per dose
- Form used in Doctor's Best and Healthy Origins products
- Pre-reduced active form — no conversion step required
- Some studies show higher peak plasma levels at equivalent dose
- May be preferable in older adults with impaired conversion capacity
- Less RCT evidence for specific outcomes vs ubiquinone
- Generally higher cost per dose
- Patented as Kaneka QH® in most branded products
A 2020 review by Mantle and Dybring in the journal Antioxidants (Basel) examined absorption data across formulations and concluded that the absorption advantage of ubiquinol over ubiquinone is formulation-dependent.3 High-quality ubiquinone suspended in an oil matrix — such as the softgels sold at Probiotic.ie — can achieve comparable plasma levels to ubiquinol in most adults under 60. For older adults (70+) or those with demonstrated mitochondrial disease, ubiquinol may offer a marginal absorption advantage. For the general adult population, ubiquinone at 100mg in an oil-based softgel is a well-supported starting point.
CoQ10 and statins: what the evidence shows
The connection between statins and CoQ10 depletion is one of the most clinically important — and most frequently asked about — aspects of CoQ10 supplementation in Ireland, where statin prescribing rates are among the highest in Europe.
Statins (HMG-CoA reductase inhibitors) work by blocking the mevalonate pathway to reduce cholesterol synthesis. This same pathway is required for CoQ10 biosynthesis. As a result, all statins reduce endogenous CoQ10 production in a dose-dependent manner. Langsjoen and Langsjoen (Biofactors, 2003) documented this depletion mechanism and reported measurable reductions in plasma CoQ10 in statin-treated patients.9
Statin-associated muscle symptoms (SAMS) — including myalgia, muscle weakness, and exercise intolerance — affect an estimated 5–10% of statin users and are a leading cause of statin discontinuation. The hypothesis that CoQ10 depletion contributes to SAMS has driven significant research interest.
50 patients with mild-to-moderate SAMS were randomised to 50mg CoQ10 twice daily or placebo for 30 days. The CoQ10 group showed statistically significant reductions in muscle pain intensity (p=0.016) and interference with daily activities (p=0.045). No significant adverse effects were observed. This is a well-designed RCT with a clear primary endpoint.
Citation: Skarlovnik A et al. Med Sci Monit. 2014;20:2183–2188. — PubMed
The 2021 updated meta-analysis by Xu et al. in the Journal of the American Heart Association found a statistically significant reduction in SAMS pain scores with CoQ10 versus placebo (pooled effect size SMD −0.63, 95% CI −1.04 to −0.22). However, I² heterogeneity was high across trials, reflecting variation in dose (ranging from 50mg to 600mg/day), CoQ10 form, and study duration. Not all individual trials showed benefit. The authors urged caution in drawing definitive conclusions.
Citation: Xu Z et al. J Am Heart Assoc. 2021;10(13):e021169. — PubMed
CoQ10 is not licensed by the HPRA as a treatment for statin-associated muscle symptoms. It is sold in Ireland as a food supplement under FSAI regulation. If you are taking statins and experiencing muscle symptoms, consult your GP — do not self-manage without medical input. Your GP may adjust your statin dose, switch you to a different statin, or discuss supplementation as a complementary approach.
CoQ10 side effects and safety
CoQ10 has a well-established safety profile at standard supplemental doses. The majority of clinical trials at doses up to 1,200mg per day have not identified serious adverse effects attributable to CoQ10.10
| Effect | Frequency | Context |
|---|---|---|
| Mild GI symptoms (nausea, loose stools) | Uncommon | Dose-dependent; reduced by taking with food |
| Insomnia / sleep disturbance | Rare | Reported at higher doses (>300mg); take earlier in day |
| Headache | Rare | Reported in small number of subjects across trials |
| Blood pressure lowering | Possible | Relevant for those on antihypertensives — consult GP |
| Warfarin interaction | Clinically relevant | Structural similarity to vitamin K; may reduce INR. Consult GP if taking warfarin. |
| Serious adverse effects | Not reported | Not identified in trials up to 1,200mg/day |
If you take warfarin (a blood thinner), do not take CoQ10 without consulting your GP or anticoagulation clinic first. CoQ10 has structural similarities to vitamin K and may affect your INR. If you take antihypertensive medication, CoQ10 may have additive blood pressure-lowering effects — monitor your blood pressure and discuss with your GP. If you are pregnant or breastfeeding, do not take CoQ10 without medical advice.
How long does CoQ10 take to work?
Expectations should be set based on the pharmacokinetics and trial durations, not anecdote. The timeline below is derived from published study designs and pharmacokinetic data.
Where to buy CoQ10 in Ireland
CoQ10 supplements are available in Ireland from pharmacies (Boots, Lloyds), health food chains (Holland & Barrett, Nourish), and specialist online retailers. The key purchasing considerations are dose, formulation (oil-based softgel vs. dry powder capsule), form (ubiquinone vs. ubiquinol), and price per dose.
Probiotic.ie stocks two CoQ10 100mg products from established US supplement brands — both in oil-based softgel format for superior absorption. Both are food supplements regulated in Ireland under FSAI guidelines.
| Product | Dose | Count | Price | Cost/Dose | Form | Notable |
|---|---|---|---|---|---|---|
| Doctor's Best CoQ10 100mg | 100mg | 120 softgels | €34.75 | €0.29 | Ubiquinone / olive oil | Contains BioPerine® (black pepper extract 5mg) to support absorption |
| Healthy Origins CoQ10 100mg | 100mg | 60 softgels | €31.95 | €0.53 | Ubiquinone / cold-pressed olive oil | Free from gluten, soy, dairy, egg, nuts, shellfish. Kosher gelatine. |
Doctor's Best includes BioPerine® (standardised black pepper extract, 5mg) — a patented piperine extract that has been shown to enhance CoQ10 bioavailability in some formulation studies. This makes it the better value option for most buyers: 120 softgels at €0.29 per day provides a 4-month supply.
Healthy Origins is the choice if allergen-free formulation is a priority. Its free-from credential (gluten, soy, dairy, egg, nuts, shellfish) is more comprehensive than most competitors. At 60 softgels, it is a practical first-purchase to trial before committing to a larger supply.
Doctor's Best CoQ10 100mg — 120 Softgels
Ubiquinone 100mg per softgel in olive oil, with BioPerine® (black pepper extract 5mg). 120-day supply at one softgel daily. The best cost-per-dose CoQ10 100mg available in Ireland.
Nationwide Ireland delivery · Tracked shipping · Free over €75 · FSAI-regulated food supplement · Not a medicine
Frequently Asked Questions
CoQ10 (coenzyme Q10, also called ubiquinone) is a fat-soluble compound found in virtually every cell in the body. It plays a central role in the mitochondrial electron transport chain — the process by which cells generate ATP (energy) — and functions as a fat-soluble antioxidant. It is used as a food supplement to support cellular energy production, particularly where endogenous levels may be reduced due to age, statin therapy, or high physiological demand. In Ireland, it is regulated as a food supplement by the FSAI.
CoQ10 is used to support mitochondrial energy production, provide fat-soluble antioxidant protection, and supplement levels depleted by statin medications (HMG-CoA reductase inhibitors). Research has examined its potential in cardiac populations, statin users with muscle symptoms, male reproductive function, and female oocyte quality. No health claims for CoQ10 are currently authorised under EC Regulation 1924/2006 as applied in Ireland — it is not licensed to treat, cure, or prevent any disease.
Ubiquinone is the oxidised form of CoQ10 and is the most extensively studied in clinical trials. Ubiquinol is the reduced (active antioxidant) form. The body converts ubiquinone to ubiquinol enzymatically. A 2020 review by Mantle and Dybring (Antioxidants, Basel) found that absorption differences between forms are formulation-dependent, and that high-quality ubiquinone in an oil-based softgel can achieve comparable bioavailability to ubiquinol in most adults. Both Doctor's Best and Healthy Origins CoQ10 100mg softgels sold at Probiotic.ie contain ubiquinone suspended in olive oil.
There is no established EU Reference Intake for CoQ10. The most common dose in clinical trials is 100mg per day, which is the starting dose for most general population applications including statin users. Higher doses of 200mg to 600mg per day have been used in male fertility trials and some cardiac studies. Take CoQ10 with a fat-containing meal for best absorption. Do not exceed the stated dose on the product label without guidance from a GP or pharmacist.
Statins block the mevalonate pathway, reducing both cholesterol and endogenous CoQ10 synthesis (documented by Langsjoen and Langsjoen, Biofactors, 2003). A 2014 RCT by Skarlovnik et al. (Medical Science Monitor) found 100mg daily CoQ10 significantly reduced mild-to-moderate statin-related muscle symptoms at 30 days. However, a 2021 meta-analysis by Xu et al. (Journal of the American Heart Association) found mixed results across trials due to high heterogeneity. Always consult your GP before taking CoQ10 alongside statin therapy.
CoQ10 is used by women primarily for reproductive support and antioxidant protection. A 2015 study by Ben-Meir et al. (Aging Cell) demonstrated that CoQ10 supplementation restored mitochondrial function in oocytes of aged mice and improved fertilisation rates. Women over 35 pursuing conception or undergoing IVF are the most common group using CoQ10 for this purpose. These findings are based primarily on animal model and mechanistic data — discuss with a fertility specialist before use.
The primary evidence for CoQ10 in men relates to sperm function. A 2013 meta-analysis by Lafuente et al. (Journal of Assisted Reproduction and Genetics) reviewed five RCTs and found significant improvements in sperm motility, morphology, and concentration with CoQ10 supplementation versus placebo. The mechanism is mitochondrial — sperm rely on ATP for flagellar movement. Doses studied ranged from 200mg to 600mg per day over 3 to 6 months. Note that 100mg per day is the dose in the products stocked at Probiotic.ie, which is lower than most fertility trial doses.
CoQ10 is generally well-tolerated. Reported side effects at standard doses include mild gastrointestinal symptoms (nausea, loose stools) — which are reduced by taking with food — and rarely, insomnia at higher doses. CoQ10 may interact with warfarin (reduced INR) and may have additive blood pressure-lowering effects in those taking antihypertensives. No serious adverse effects have been identified in clinical trials at doses up to 1,200mg per day. Consult your GP or pharmacist before use if you take any medication.
CoQ10 is available in pharmacies, health food stores, and online in Ireland. Probiotic.ie stocks Doctor's Best CoQ10 100mg (120 softgels, €34.75, with BioPerine®) and Healthy Origins CoQ10 100mg (60 softgels, €31.95), both in oil-based softgels for optimal absorption, with nationwide tracked Ireland delivery. No prescription is required — CoQ10 is a food supplement in Ireland, not a medicine.
Plasma CoQ10 levels rise within 1–2 weeks of consistent daily supplementation. Functional changes take longer: statin muscle symptom trials have used 30-day endpoints; general energy and cardiac trials typically run 8–12 weeks; fertility parameter studies run 3–6 months. If no change is perceived by 12 weeks at an appropriate dose, reassess with a healthcare professional.
CoQ10 is generally safe alongside most supplements. The primary interaction to be aware of is with warfarin (anticoagulant) — CoQ10 has structural similarity to vitamin K and may reduce warfarin's effectiveness; consult your GP or anticoagulation clinic before use. Those taking antihypertensive medication should monitor blood pressure, as additive effects are possible. Statin users should inform their GP. There is insufficient evidence to confirm safety during pregnancy or breastfeeding.
No. CoQ10 is classified as a food supplement in Ireland, not a medicine. It is regulated by the FSAI (Food Safety Authority of Ireland) under SI 506 of 2007 and the Food Supplements Regulations 2022. It is not licenced as a medicinal product by the HPRA and cannot be claimed to diagnose, treat, cure, or prevent any disease. No prescription is required to purchase CoQ10 in Ireland.
Related Guides
Sources
- Flowers N et al. Effects of coenzyme Q10 supplementation on cardiac outcomes in patients with heart failure: a systematic review and meta-analysis. Cochrane Database Syst Rev. 2023. — PubMed 36374552
- Hernández-Camacho JD et al. Coenzyme Q10 supplementation in aging and disease. Front Physiol. 2018;9:44. — PubMed 29459830
- Mantle D, Dybring A. Bioavailability of Coenzyme Q10: An Overview of the Absorption Process and Subsequent Metabolism. Antioxidants (Basel). 2020;9(5):386. — PubMed 32380795
- Skarlovnik A et al. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med Sci Monit. 2014;20:2183–2188. — PubMed 25391864
- Xu Z et al. Effect of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials. J Am Heart Assoc. 2021;10(13):e021169. — PubMed 34169734
- Ben-Meir A et al. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell. 2015;14(5):887–895. — PubMed 26111777
- Lafuente R et al. Coenzyme Q10 and male infertility: a meta-analysis. J Assist Reprod Genet. 2013;30(9):1147–1156. — PubMed 23912751
- Sánchez-Cuesta A et al. The antioxidant role of coenzyme Q. Redox Biol. 2023;62:102674. — PubMed 36931078
- Langsjoen PH, Langsjoen AM. The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. Biofactors. 2003;18(1–4):101–111. — PubMed 14695925
- Garrido-Maraver J et al. Coenzyme Q10 therapy. Mol Syndromol. 2014;5(3–4):187–197. — PubMed 25126052